China Pharmaceutical University | China

Author Profile

Early Academic Pursuits 🎓

Dr. Rengui Saxu began his academic journey at Shenyang Medical College, where he pursued a degree in Clinical Medicine Science from 2012 to 2017. During his studies, he completed an internship at Shenyang Central Hospital in 2017, gaining hands-on experience in clinical practice. His academic dedication earned him the National Encouragement Scholarship and the title of Outstanding Graduate, marking his potential as a rising scholar in the field of medicine. Continuing his academic path, Dr. Saxu pursued a Master of Pharmacy Engineering at Tianjin University of Science & Technology from 2017 to 2020. During this time, he took on leadership roles, notably serving as the Head of the Academic Department of the University Graduate Association. His work in pharmacy engineering was recognized with the Zhixing Scholarship for Postgraduate Students.

Professional Endeavors 🏅

Dr. Saxu is currently engaged in advanced research as a Ph.D. candidate in Pharmacology at China Pharmaceutical University (2021-2025). He works under the supervision of Yong Yang, a prominent figure in pharmacological research, and Harvest F. Gu, Chief Scientist at Karolinska Medical School in Sweden. His research spans crucial areas in pharmacology, focusing on drug development and the mechanisms of disease, particularly in relation to diabetes, kidney disease, and cancer.

Contributions and Research Focus 🔬

Dr. Saxu's research contributions are vast, with a focus on pharmacological innovations and therapeutic interventions for diseases like diabetes and cancer. One of his notable patents is a Chinese patent for a method involving selenium-substituted axitinib, which offers anti-tumor applications. His academic publications reflect his deep involvement in cutting-edge research:

His studies on asymmetries in adrenal glands and their role in glucocorticoid production provide insights into diabetes-related obesity.
He has explored the therapeutic potential of Abelmoschus manihot (L.) in treating diabetic nephropathy via the gut-kidney axis, contributing to the advancement of herbal medicine in disease management.
Dr. Saxu has also investigated how Huangkui capsules inhibit aldosterone synthesis in diabetic kidney disease, a promising direction for traditional Chinese medicine.

Accolades and Recognition 🏆

Dr. Saxu's academic excellence has been recognized through numerous prestigious awards:

National Encouragement Scholarship
Zhixing Scholarship for Postgraduate Students
Doctoral Research Incentive Scholarship
Outstanding Doctoral Scholarship

These accolades reflect his commitment to research and innovation in the field of pharmacology.

Impact and Influence 🌍

Dr. Saxu's research has had a considerable impact on the medical and pharmacological fields, particularly in the treatment of diabetes and kidney disease. His work on drug therapy and natural compound-based treatments has opened new avenues for understanding and combating complex diseases. His research not only influences medical practices in China but also has international implications, especially in areas related to drug efficacy and safety.

Legacy and Future Contributions 🚀

Dr. Saxu’s future contributions are poised to advance pharmacological research significantly, especially in the areas of cancer therapy and chronic disease management. As a researcher under highly esteemed mentors like Yong Yang and Harvest F. Gu, his ongoing work will likely lead to breakthroughs in targeted therapies and personalized medicine. In the years to come, Dr. Saxu's work will continue to shape the landscape of pharmaceutical sciences, offering hope for more effective and less harmful treatment options. His contributions to medical research, especially in oncology and diabetes, will leave a lasting legacy in global healthcare.

Publications

📜 Higher Steroid Production in the Right Adrenal Gland Compared to the Left One in db/db Mice, a Model of Type 2 Diabetic Obesity

Authors: Rengui Saxu, Qiming Luo, Yong Yang, Harvest F. Gu
Journal: International Journal of Molecular Sciences
Year: 2024

📜 Asymmetries of Left and Right Adrenal Glands in Neural Innervation and Glucocorticoids Production

Authors: Rengui Saxu, Yong Yang, Harvest F. Gu
Journal: International Journal of Molecular Sciences
Year: 2023

Ylenia Della Rocca | Medicine and Dentistry | Best Researcher Award

Published on 20/09/202420/09/2024 by Book of Award

Dr. Ylenia Della Rocca | Medicine and Dentistry | Best Researcher Award

University of Chieti | Italy

Author Profile

Scopus

Orcid

🌱 Early Academic Pursuits

Dr. Ylenia Della Rocca’s academic journey began with exceptional achievements in biotechnology. In 2018, she earned her degree in Biotechnology with a perfect score of 110/110 cum laude from the University of L'Aquila. Her thesis, centered on "Hairy Cell Leukemia," set the stage for her future in oncohematological genetics. She continued to excel with a Master’s degree in Medical Biotechnology, again graduating with academic praise. Her research on the HLA-G 3' UTR region in kidney transplantation at the National Research Center solidified her expertise in medical biotechnology.

🏥 Professional Endeavors

Currently, Dr. Della Rocca serves as a Researcher Technologist and Subject Expert in Histology and Embryology at the University of Chieti. Her impressive academic trajectory culminated in a Ph.D. in "Innovative Technologies in Clinical Medicine & Dentistry" in 2024. As part of her doctoral research, she developed a new iPS cell line during her tenure at the University of Barcelona and Josep Carreras Leukaemia Research Institute. Beyond her role as a researcher, Dr. Della Rocca has been a prominent speaker at numerous international conferences, where her work has garnered significant recognition.

🔬 Contributions and Research Focus

Dr. Della Rocca’s research is at the forefront of biotechnology and regenerative medicine. Her completed and ongoing projects include the development of three-dimensional disease models, studies on tissue differentiation, and the establishment of new iPS cell lines. She has also been pivotal in creating innovative models for carcinogenesis research. Her current patent under review—"Pluripotent Stem Cells Induced by Autologous Gingival Stem Cells and Extracellular Vesicles: A Novel Approach for Cardiac Regeneration"—underscores her groundbreaking contributions to stem cell therapies and regenerative medicine.

🏆 Accolades and Recognition

Dr. Della Rocca’s research career has been marked by numerous accolades, including two prestigious awards for her scientific achievements. She has been a Guest Editor for special issues in renowned journals like the International Journal of Molecular Sciences and has served as a Review Editor for Frontiers in Genetics and Frontiers in Cell and Developmental Biology. Her citation index of 10 reflects the growing impact of her research in the scientific community.

🌍 Impact and Influence

Dr. Della Rocca’s work transcends academic research, as evidenced by her collaborations with top universities and research institutes worldwide, including the University of Barcelona, IRCCS Sicily, and the University of Montreal. She is an active member of the Italian Society of Anatomy and Histology and the Sigma Xi Scientific Research Honor Society. Dr. Della Rocca’s commitment to healthcare is further exemplified by her founding of Associazione Sorrisi in Ospedale (A.S.I.O.), a third-sector organization aimed at improving patient care in hospitals.

🔮 Legacy and Future Contributions

As a leader in the fields of stem cells, bioengineering, and regenerative medicine, Dr. Ylenia Della Rocca continues to push the boundaries of scientific knowledge. Her contributions to cell-free therapies and the development of three-dimensional models hold immense promise for future medical applications. With her ongoing work in stem cell regeneration and epigenetic research, Dr. Della Rocca is poised to shape the next frontier of clinical and research tools, leaving a lasting legacy in biotechnology.

Publications

📄 Autologous hGMSC-Derived iPS: A New Proposal for Tissue Regeneration
Authors: Ylenia Della Rocca, Francesca Diomede, Fanì Konstantinidou, Valentina Gatta, Liborio Stuppia, Umberto Benedetto, Marco Zimarino, Paola Lanuti, Oriana Trubiani, Jacopo Pizzicannella
Journal: International Journal of Molecular Sciences
Year: 2024

📄 Biological Effects of PMMA and Composite Resins on Human Gingival Fibroblasts: An In Vitro Comparative Study
Authors: Ylenia Della Rocca, Enrico Matteo Traini, Oriana Trubiani, Tonino Traini, Antonella Mazzone, Guya Diletta Marconi, Jacopo Pizzicannella, Francesca Diomede
Journal: International Journal of Molecular Sciences
Year: 2024

Jiang hua Yang | Medicine and Dentistry | Best Researcher Award

Published on 19/07/202420/07/2024 by Book of Award

Dr. Jianghua Yang | Medicine and Dentistry | Best Researcher Award

Yijishan Hospital | China

Author Profile

Scopus

Early Academic Pursuits

Dr. Jianghua Yang began his academic journey in the medical field with a focus on infectious diseases. His foundational studies laid the groundwork for a career dedicated to understanding and combating a variety of infectious diseases. Over the years, Dr. Yang has honed his expertise and developed a deep research interest in several key areas, including tuberculosis, severe fever with thrombocytopenia syndrome, schistosomiasis, and hepatitis.

Professional Endeavors

Dr. Jianghua Yang is currently associated with the Department of Infectious Diseases at Yijishan Hospital of Wannan Medical College in Wuhu, Anhui, China. In his professional role, he has undertaken significant research projects and contributed extensively to the field of infectious diseases. His work is characterized by a commitment to advancing medical knowledge and improving patient outcomes through rigorous scientific inquiry and collaboration with other researchers.

Contributions and Research Focus

Dr. Yang's research spans several critical areas in infectious diseases. His studies on tuberculosis have been published in reputable journals such as "Tuberculosis (Edinb)" and the "International Journal of Infectious Diseases". His work on severe fever with thrombocytopenia syndrome has appeared in the "Journal of Medical Virology" and the "Japanese Journal of Infectious Diseases". Additionally, Dr. Yang has investigated schistosomiasis, with his findings published in "Scientific Reports" and "Journal of Cancer". His research on hepatitis has been featured in the "European Journal of Gastroenterology & Hepatology" and "BMC Gastroenterology". These contributions have not only enhanced the understanding of these diseases but have also provided valuable insights into their diagnosis, treatment, and management.

Accolades and Recognition

Throughout his career, Dr. Yang has received recognition for his impactful research and contributions to the field of infectious diseases. His publications have been cited by peers, reflecting the significance and influence of his work. Dr. Yang's dedication to advancing medical science has earned him respect and acknowledgment within the academic and medical communities.

Impact and Influence

Dr. Yang's research has had a substantial impact on the understanding and treatment of infectious diseases. His work on tuberculosis and severe fever with thrombocytopenia syndrome has informed clinical practices and guided further research in these areas. By elucidating the complexities of diseases such as schistosomiasis and hepatitis, Dr. Yang has contributed to the development of more effective diagnostic and therapeutic strategies, thereby improving patient care and outcomes.

Legacy and Future Contributions

Dr. Jianghua Yang's legacy in the field of infectious diseases is marked by his significant research contributions and his commitment to advancing medical knowledge. As he continues his work, Dr. Yang is poised to make further groundbreaking discoveries that will enhance the understanding of infectious diseases and lead to better health outcomes worldwide. His ongoing research and dedication to scientific excellence will undoubtedly inspire future generations of researchers and healthcare professionals.

Notable Publications

Construction of an early differentiation diagnosis model for patients with severe fever with thrombocytopenia syndrome and hemorrhagic fever with renal syndrome 2024

Prevalence and impact of viral myocarditis in patients with severe fever with thrombocytopenia syndrome 2024

Clinicopathological characteristics and its association with digestive system tumors of 1111 patients with Schistosomiasis japonica 2023 (1)

A risk prediction model for acute kidney injury in patients with pulmonary tuberculosis during anti-tuberculosis treatment 2022 (4)

Chansokhon Ngan | Medicine and Dentistry | Best Researcher Award

Published on 10/04/202410/04/2024 by Book of Award

Mr. Chansokhon Ngan | Medicine and Dentistry | Best Researcher Award

West China Hospital of Sichuan University | China

Author Profile

Orcid

Early Academic Pursuits

Mr. Chansokhon Ngan embarked on his academic journey with a fervent dedication to advancing knowledge in critical care medicine. As a PhD student specializing in Critical Care Medicine at West China Hospital of Sichuan University, he cultivated a strong foundation in research methodologies, data analysis, and clinical practice. His academic pursuits equipped him with the necessary skills to address complex clinical challenges and contribute meaningfully to patient care and medical research.

Professional Endeavors

Throughout his career, Mr. Ngan has been committed to advancing knowledge in critical care medicine through his research endeavors. One of his notable studies, titled "Cardiac index and heart rate as prognostic indicators for mortality in septic shock: A retrospective cohort study from the MIMIC-IV," exemplifies his dedication to excellence in research. Published in Heliyon Journal, this study investigated the relationship between cardiac index (CI), heart rate (HR), and mortality in septic shock patients, utilizing sophisticated data analysis techniques.

Contributions and Research Focus

Mr. Ngan's research focus revolves around critical illnesses, such as septic shock and acute respiratory distress syndrome (ARDS). His contributions to the field include studies on prognostic indicators for mortality in septic shock and predicting the early incidence and stratification of ARDS. Additionally, he is engaged in investigating the application of critical care ultrasound in managing acute respiratory and circulatory dysfunction, aiming to enhance clinical practices and improve patient outcomes.

Accolades and Recognition

Mr. Ngan's dedication to excellence in research has earned him recognition in the medical community. His study on prognostic indicators for mortality in septic shock, published in Heliyon Journal, showcases his commitment to advancing knowledge in critical care medicine. His contributions have been acknowledged for their implications for clinical practice and patient care.

Impact and Influence

Mr. Ngan's research endeavors have made a significant impact on the field of critical care medicine. By investigating prognostic indicators for mortality in septic shock and exploring the application of critical care ultrasound, he has contributed valuable insights that have the potential to improve patient outcomes and enhance clinical practices. His work has influenced the way healthcare providers monitor and manage critical illnesses, leading to more informed decision-making and improved patient care.

Legacy and Future Contributions

As Mr. Ngan continues his academic journey, he remains dedicated to making meaningful contributions to the field of critical care medicine. His research legacy encompasses a commitment to excellence, innovation, and improving patient outcomes. Through his ongoing endeavors, he aims to advance knowledge in critical care medicine, ultimately leaving a lasting impact on the field and paving the way for enhanced clinical practices and patient care.

Notable Publications

Yannick Allanore | Medicine and Dentistry | Best Research Article Award

Published on 08/01/202408/01/2024 by Book of Award

Prof. Yannick Allanore | Medicine and Dentistry | Best Research Article Award

Université Paris Cité | France

Author Profile

Scopus

Early Academic Pursuits

Yannick Allanore commenced his academic journey at Paris Descartes University, obtaining a Master's degree in 1999, followed swiftly by a Medical Doctor certification in 2000. His commitment to specialization in Rheumatology led to a Certification in Rheumatology in 2001. His profound interest in the field culminated in a thesis on "Oxidative stress and systemic sclerosis," earning him a Physician Doctor title in 2004.

Professional Endeavors

His academic tenure unfolded as an Assistant Professor at Paris Descartes University's Rheumatology department at Cochin Hospital from 2005 to 2008. Allanore's research prowess was acknowledged with a Research Habilitation in 2005, focusing on the pathogenesis of systemic sclerosis. Subsequently, he served as a Post-doctoral researcher at INSERM U781 and U1016, delving into the genetic bases and chronic inflammation of systemic sclerosis.

Contributions and Research Focus

Allanore leads a groundbreaking research team at Institut Cochin, delving into pathogenesis and innovative therapies for fibro-inflammatory rheumatic diseases since 2018. His research delves into genetic and pathophysiological aspects of systemic sclerosis, cardio-pulmonary involvement, clinical trials, and endothelial progenitor cells in rheumatic diseases.

Accolades and Recognition

Professor Allanore boasts a substantial publication record, exceeding 480 papers in peer-reviewed journals, showcasing an impressive H-Index of 71. His contributions have earned him memberships in esteemed societies such as the French Rheumatology Society, American College of Rheumatology, and significant roles within EUSTAR and the World Scleroderma Foundation.

Impact and Influence

His leadership roles, including former chairman of EUSTAR and current vice-director of Institut Cochin, testify to his impact on the global rheumatology community. Allanore's multifaceted approach—integrating clinical research, genetic studies, cellular biology, and animal model platforms—underlines his comprehensive influence on understanding and treating chronic inflammatory rheumatic diseases.

Legacy and Future Contributions

Yannick Allanore's legacy lies in his pivotal contributions to unraveling the complexities of systemic sclerosis and related conditions. His leadership in research and academia continues to pave the way for innovative therapies and a deeper comprehension of these debilitating diseases. As vice-director of Institut Cochin, his ongoing dedication promises further advancements in the field of rheumatology.

Notable Publications

Phenotyping by persistent inflammation in systemic sclerosis associated interstitial lung disease: a EUSTAR database analysis 2023 (1)

Characteristics of patients with difficult-to-treat rheumatoid arthritis in a French single-centre hospital 2023 (2)

Comparison of subcutaneous and oral methotrexate initiation in rheumatoid arthritis in current practice 2023 (1)